Aurobindo Pharma snaps 12-day winning streak after USFDA update on subsidiary's API unit
CNBC-TV18

Aurobindo Pharma shares fell nearly 2% after the US FDA issued a Form 483 with
a VAI classification for its subsidiary Apitoria Pharma Private Limited's
manufacturing facility.








